Bennett Associates Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Bennett Associates Wealth Management's LLY Position: Q3 2026 in Review
Bennett Associates Wealth Management reduced its Eli Lilly (LLY) stake by 4.7% in Q3 2026, selling an estimated $44.8K and leaving 765 shares worth $885K. The position accounts for 0.54% of the portfolio, ranked #25.
Bennett Associates Wealth Management first reported a position in LLY in Q3 2025 and has held it in 5 quarters since. The position peaked at $963K in Q2 2026. 1,509 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Bennett Associates Wealth Management held 765 shares of Eli Lilly worth $885K as of Q3 2026.
- Bennett Associates Wealth Management sold 38 Eli Lilly shares in Q3 2026, an estimated $44.8K.
- Eli Lilly made up 0.54% of Bennett Associates Wealth Management's portfolio in Q3 2026, its #25 holding.
- Bennett Associates Wealth Management first reported a position in Eli Lilly in Q3 2025 and has held it in 5 quarters since.
- Bennett Associates Wealth Management's Eli Lilly position peaked at $963K in Q2 2026.
- 1,509 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Bennett Associates Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.